AI Playbook for Dilute Specimen MRO Decision

A DOT-regulated CDL driver submitted a urine specimen with creatinine of 18 mg/dL and specific gravity of 1.002. The laboratory reported the specimen as dilute negative. The employer's DER is asking whether to accept the result, require an observed re-collection, or take immediate action. The driver's route resumes in 6 hours.

When to use this playbook

• Use this playbook when the decision looks like the situation above: A DOT-regulated CDL driver submitted a urine specimen with creatinine of 18 mg/dL and specific gravity of 1.002.
• It is a fit when you have source files in hand and need a structured, reviewable analysis — not a generic chat answer about "Dilute Specimen MRO Decision".
• Do not use it as a substitute for licensed, legal, clinical, or authorized official judgment in the domain.

What you'll need

• Laboratory chain of custody form and results
• DOT 49 CFR Part 40 dilute specimen guidelines
• Driver's prior drug test history
• Employer's drug and alcohol policy
• DER inquiry regarding immediate action

Attachments: Documents (Documents)

You are a Medical Review Officer making a dilute specimen decision for a DOT-regulated CDL driver. I am attaching:

Work only from the attached source files. If a conclusion is not supported, say so.

Produce:
1. Classify this dilute result under DOT 49 CFR Part 40: is creatinine 18 mg/dL and specific gravity 1.002 within the dilute range, and what is the required MRO action?
2. Determine whether an immediate re-collection under direct observation is required or optional at this creatinine/specific gravity level.
3. Assess whether the dilute result, even as a negative, requires any employer notification beyond standard reporting.
4. Identify the medical explanations that could legitimately explain a dilute specimen and whether any should be explored with the donor before final reporting.
5. Tell the DER exactly what action is permitted in the next 6 hours and what documentation is required for the MRO file.

Call out where independent models are likely to disagree, and list follow-up documents a reviewer should request.

What to expect

• DOT 49 CFR Part 40 classification of dilute result
• Observed re-collection determination
• Employer notification requirements
• Medical explanation assessment
• DER permitted actions and documentation requirements

Review before you act

• Validate this output against source files before relying on it: Classify this dilute result under DOT 49 CFR Part 40: is creatinine 18 mg/dL and specific gravity 1.002 within the dilute range, and what is the required MRO action?.
• Validate this output against source files before relying on it: Determine whether an immediate re-collection under direct observation is required or optional at this creatinine/specific gravity level.
• Validate this output against source files before relying on it: Assess whether the dilute result, even as a negative, requires any employer notification beyond standard reporting.
• Validate this output against source files before relying on it: Identify the medical explanations that could legitimately explain a dilute specimen and whether any should be explored with the donor before final reporting.
• Confirm every cited figure, date, counterparty, or requirement against the attached originals — models compress and can drop a qualifier.
• Treat disagreement between models as a review item, especially on classification, materiality, and recommended next action.
• Do not authorize an operational, clinical, legal, credit, or enforcement action solely because the models agree.